These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 5309487)
21. Hong Kong influenza in the Royal Air Force 1968-70. Miller DL; Reid D; Daimond JR; Pereira MS; Chakraverty P J Hyg (Lond); 1973 Sep; 71(3):535-47. PubMed ID: 4518353 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of a temperature-sensitive influenza virus in elderly and chronically ill subjects. Douglas RG; Bentley DW; Betts RF; Zaky DA; Roth FK; Murphy BR Am Rev Respir Dis; 1976 Mar; 113(3):293-300. PubMed ID: 1259238 [TBL] [Abstract][Full Text] [Related]
23. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines. Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421 [TBL] [Abstract][Full Text] [Related]
24. [Interferon formation in persons vaccinated with genetically heterogeneous strains of Hong Kong influenza]. Nekliudova LI; Bektemirov TA Vopr Virusol; 1971; 16(6):689-92. PubMed ID: 5141614 [No Abstract] [Full Text] [Related]
25. An electroaerosol device for group vaccination against influenza. Grinshpun L; Priimägi L; Subi K; Reinet J; Visnapuu L Z Erkr Atmungsorgane; 1978 Mar; 150(3):237-8. PubMed ID: 695738 [TBL] [Abstract][Full Text] [Related]
26. Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and Trivalent A/USSR/77 (H1N1)-A/TEXAS/77 (H3N2)-B/Hong Kong/72 vaccines. Brandriss MW; Betts RF; Mathur U; Douglas RG Am Rev Respir Dis; 1981 Dec; 124(6):681-4. PubMed ID: 7316272 [TBL] [Abstract][Full Text] [Related]
27. Preliminary results of oral influenza vaccination with live attenuated viruses. DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972 [TBL] [Abstract][Full Text] [Related]
28. Intention to receive influenza vaccination prior to the summer influenza season in adults of Hong Kong, 2015. Yang L; Cowling BJ; Liao Q Vaccine; 2015 Nov; 33(48):6525-8. PubMed ID: 26478202 [TBL] [Abstract][Full Text] [Related]
29. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial. Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482 [TBL] [Abstract][Full Text] [Related]
30. Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine. Knight V; Couch RB; Douglas RG; Tauraso NM Bull World Health Organ; 1971; 45(6):767-71. PubMed ID: 5317012 [TBL] [Abstract][Full Text] [Related]
31. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD Pediatrics; 1982 Apr; 69(4):404-8. PubMed ID: 7070886 [TBL] [Abstract][Full Text] [Related]
32. Antigenic response to influenza virus in man. I. Neutralizing antibody response to inactivated monovalent A2 vaccine as related to prior influenza exposure. Brown P; Gajdusek DC; Morris JA Am J Epidemiol; 1969 Oct; 90(4):327-35. PubMed ID: 5823443 [No Abstract] [Full Text] [Related]
33. [Antibody response in humans to A/New Jersey/76 influenza vaccine (author's transl)]. Pontecorvo M; Di Tommaso I; Simi M Ann Sclavo; 1976; 18(3):509-14. PubMed ID: 1020964 [TBL] [Abstract][Full Text] [Related]
34. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans. Závadová H Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207 [No Abstract] [Full Text] [Related]
35. Influenza vaccines in children. Comparison of new cetrimonium bromide and standard ether-treated vaccines. Gross PA; Quinnan GV; Gaerlan PF; Denning CR; Lazicki M; Bernius M Am J Dis Child; 1983 Jan; 137(1):26-8. PubMed ID: 6847954 [TBL] [Abstract][Full Text] [Related]
36. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines]. Sarateanu DE; Ehrengut W Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399 [No Abstract] [Full Text] [Related]
37. [Research on influenza vaccination with A2 + B vaccine]. Bellelli E; Nardi G; Bracchi U; Tanzi ML; Monaci V; Sansebastiano G Ann Sclavo; 1971; 13(5):584-96. PubMed ID: 5153401 [No Abstract] [Full Text] [Related]
38. Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14. Chiu SS; Feng S; Chan KH; Lo JY; Chan EL; So LY; Cowling BJ; Peiris JS Vaccine; 2016 Apr; 34(19):2164-9. PubMed ID: 27013437 [TBL] [Abstract][Full Text] [Related]
39. Small-scale field trial with neuraminidase vaccine. Vonka V; Závadová H; Brůj J; Skocil V; Janout V; Uvizl M; Kotíková J Dev Biol Stand; 1977 Jun 1-3; 39():337-9. PubMed ID: 342313 [TBL] [Abstract][Full Text] [Related]